ArticleAnnals of translational medicine2026
Breaking through the azacitidine plateau?-venetoclax in high-risk myelodysplastic syndrome.
Yuju An et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it